Lord Abbett & Company Decreased Arista Networks Com (ANET) Stake; Protagonist Therapeutics (PTGX) SI Increased By 1.35%

September 17, 2017 - By marketbeat

Lord Abbett & Company decreased Arista Networks Inc Com (ANET) stake by 1.83% reported in 2016Q4 SEC filing. Lord Abbett & Company sold 3,710 shares as Arista Networks Inc Com (ANET)’s stock rose 21.01%. The Lord Abbett & Company holds 198,628 shares with $19.22 million value, down from 202,338 last quarter. Arista Networks Inc Com now has $12.83B valuation. The stock increased 1.15% or $2.02 on September 15, reaching $176.96. About 1.38 million shares traded or 55.36% up from the average. Arista Networks Inc (NYSE:ANET) has risen 111.25% since September 17, 2016 and is uptrending. It has outperformed by 94.55% the S&P500.

Protagonist Therapeutics Incorporated (NASDAQ:PTGX) had an increase of 1.35% in short interest. PTGX’s SI was 767,800 shares in September as released by FINRA. Its up 1.35% from 757,600 shares previously. With 59,100 avg volume, 13 days are for Protagonist Therapeutics Incorporated (NASDAQ:PTGX)’s short sellers to cover PTGX’s short positions. The SI to Protagonist Therapeutics Incorporated’s float is 10.83%. The stock increased 2.54% or $0.39 on September 15, reaching $15.75. About 90,527 shares traded or 33.42% up from the average. Protagonist Therapeutics Inc (NASDAQ:PTGX) has 0.00% since September 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical firm with a peptide technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs. The company has market cap of $266.22 million. The Company’s product pipeline includes PTG-100, PTG-200 and PTG-300. It currently has negative earnings. The Company’s primary focus is on developing oral peptide drugs that target biological pathways also targeted by marketed injectable antibody drugs.

Among 29 analysts covering Arista Networks (NYSE:ANET), 15 have Buy rating, 0 Sell and 14 Hold. Therefore 52% are positive. Arista Networks had 82 analyst reports since July 29, 2015 according to SRatingsIntel. As per Tuesday, August 4, the company rating was downgraded by Macquarie Research. The stock of Arista Networks Inc (NYSE:ANET) has “Sector Perform” rating given on Wednesday, August 31 by RBC Capital Markets. As per Friday, April 7, the company rating was downgraded by Instinet. The stock of Arista Networks Inc (NYSE:ANET) has “Equal-Weight” rating given on Monday, December 5 by Morgan Stanley. The stock of Arista Networks Inc (NYSE:ANET) earned “Buy” rating by Oppenheimer on Friday, July 14. The firm earned “Overweight” rating on Friday, August 4 by Barclays Capital. Needham maintained Arista Networks Inc (NYSE:ANET) on Tuesday, September 12 with “Buy” rating. The rating was maintained by Wells Fargo with “Buy” on Friday, July 21. Nomura downgraded the stock to “Neutral” rating in Friday, April 7 report. JP Morgan initiated the stock with “Neutral” rating in Wednesday, January 6 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com